| Patent | Date |
|---|
Anti-GARP protein
Grant 11,230,603 - Lucas , et al. January 25, 2 | 2022-01-25 |
Garp-tgf-beta Antibodies
App 20210324061 - van der Woning; Sebastian ; et al. | 2021-10-21 |
Nucleic acids encoding GARP-TGF-beta 1 antibodies
Grant 10,875,914 - van der Woning , et al. December 29, 2 | 2020-12-29 |
Method of screening for anti-GARP antibodies
Grant 10,822,424 - Lucas , et al. November 3, 2 | 2020-11-03 |
GARP-TGF-.beta. 1 IGG antibodies
Grant 10,793,627 - van der Woning , et al. October 6, 2 | 2020-10-06 |
Anti-garp Protein And Uses Thereof
App 20200181276 - Lucas; Sophie ; et al. | 2020-06-11 |
Antibody against a complex between human GARP and latent TGF-.beta.
Grant 10,604,579 - Lucas , et al. | 2020-03-31 |
Garp-tgf-beta 1 Antibodies
App 20200095311 - van der Woning; Sebastian ; et al. | 2020-03-26 |
Garp-tgf-beta 1 Antibodies
App 20190375832 - van der Woning; Sebastian ; et al. | 2019-12-12 |
GARP-TGF-beta 1 antibodies
Grant 10,479,829 - Van der Woning , et al. Nov | 2019-11-19 |
Anti-garp Protein And Uses Thereof
App 20190016811 - Lucas; Sophie ; et al. | 2019-01-17 |
Garp-tgf-beta Antibodies
App 20180327487 - Van der Woning; Sebastian ; et al. | 2018-11-15 |
Method for inhibiting the immune suppressive function of human T regulatory cells by administering an anti-GARP monoclonal antibody
Grant 10,000,572 - Lucas , et al. June 19, 2 | 2018-06-19 |
Anti-garp Protein And Uses Thereof
App 20160272717 - Lucas; Sophie ; et al. | 2016-09-22 |
Anti-garp Protein And Uses Thereof
App 20160251438 - Lucas; Sophie ; et al. | 2016-09-01 |
MAGE-C2 antigenic peptides and uses thereof
Grant 8,143,011 - Ma , et al. March 27, 2 | 2012-03-27 |
Mage-c2 Antigenic Peptides And Uses Thereof
App 20110305722 - MA; Wenbin ; et al. | 2011-12-15 |
MAGE-C2 antigenic peptides and uses therefor
App 20090233315 - Ma; Wenbin ; et al. | 2009-09-17 |
MAGE-C2 antigenic peptides and uses thereof
Grant 7,547,517 - Ma , et al. June 16, 2 | 2009-06-16 |
MAGE-C2 antigenic peptides and uses thereof
App 20040214779 - Ma, Wenbin ; et al. | 2004-10-28 |
Endogenous retrovirus tumor associated nucleic acids and antigens
Grant 6,770,456 - Coulie , et al. August 3, 2 | 2004-08-03 |
Isolated peptides derived from mage tumor rejection antigen precursors which complex with HLA-A2 molecules
Grant 6,682,731 - Townsend , et al. January 27, 2 | 2004-01-27 |
Method For Identifying Individuals Suffering From A Cellular Abnormality Some Of Whose Abnormal Cells Present Complexes Of Hla-cw 1601/mage-1 Derived Peptides, And Methods For Treating Said Individuals
Grant 6,680,056 - van der Bruggen , et al. January 20, 2 | 2004-01-20 |
Method For Identifying Individuals Suffering From A Cellular Abnormality Some Of Whose Abnormal Cells Present Complexes Of Human Leukocyte Antigen Tyrosinase Derived Peptides, And Methods For Treating Said Individuals
Grant 6,669,946 - Boon-Falleur , et al. December 30, 2 | 2003-12-30 |
Method for treating subjects by using BAGE tumor rejection antigen precursors or tumor rejection antigens
Grant 6,638,512 - Boel , et al. October 28, 2 | 2003-10-28 |
MAGE-10 encoding cDNA, the tumor rejection antigen precursor MAGE-10, antibodies specific to the molecule, and uses thereof
App 20030158388 - Rimoldi, Donata ; et al. | 2003-08-21 |
Method for determining BAGE expression
App 20030138854 - Boel, Pascale ; et al. | 2003-07-24 |
Method for identifying individuals suffering from a cellular abnormality some of whose abnormal cells present complexes of human leukocyte antigen tyrosinase derived peptides, and methods for treating said individuals
App 20020128200 - Boon-Falleur, Thierry ; et al. | 2002-09-12 |
Isolated nucleic acid molecules which encode tumor rejection antigens found in dage
Grant 6,339,149 - Coulie , et al. January 15, 2 | 2002-01-15 |
Methods for treating subjects with disorders characterized by expression of tumor rejection antigen precursors
Grant 6,201,111 - Brichard , et al. March 13, 2 | 2001-03-13 |
Method for screening for possible presence of cancer
Grant 6,022,692 - Coulie , et al. February 8, 2 | 2000-02-08 |
Mage-10 encoding cDNA, the tumor rejection antigen precursor mage-10, antibodies specific to the molecule, and uses thereof
Grant 5,908,778 - Rimoldi , et al. June 1, 1 | 1999-06-01 |
Isolated nucleic acid sequence coding for a tumor rejection antigen precursor processed to at least one tumor rejection antigen presented by HLA-A2
Grant 5,856,091 - Brichard , et al. January 5, 1 | 1999-01-05 |
Isolated cytolytic T cell line specific to complexes of HLA-B44 molecules and specific nonapeptides
Grant 5,846,826 - Coulie , et al. December 8, 1 | 1998-12-08 |
Isolated nucleic acid molecules coding for tumor rejection antigen precursor dage and uses thereof.
Grant 5,830,753 - Coulie , et al. November 3, 1 | 1998-11-03 |
Isolated, MAGE-3 derived peptides which complex with HLA-A2 molecules and uses thereof
Grant 5,591,430 - Townsend , et al. January 7, 1 | 1997-01-07 |
Isolated nucleic acid molecule which codes for a tumor rejection antigen precursor which is processed to an antigen presented by HLA-B44, and uses thereof
Grant 5,589,334 - Coulie , et al. December 31, 1 | 1996-12-31 |
Isolated nucleic acid molecules coding for BAGE tumor rejection antigen precursors
Grant 5,571,711 - van der Bruggen , et al. November 5, 1 | 1996-11-05 |
Isolated, tyrosinase derived peptides and uses thereof
Grant 5,530,096 - Wolfel , et al. June 25, 1 | 1996-06-25 |
| 